Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Puzio

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Clinical Investigation|August 30, 2008
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse modelCarolyn Waugh Kinkade, Mireia Castillo-Martin, Anna Puzio-Kuter, et al.
Otolaryngologia Polska = the Polish Otolaryngology|July 7, 2022
Innovative System for Evaluation and Rehabilitation of Human ImbalanceAnna Gawrońska, Ewa Zamysłowska-Szmytke, Magdalena Janc, et al.
ACS Medicinal Chemistry Letters|January 15, 2025
Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in DevelopmentBinh T Vu, Romyr Dominique, Bruce J Fahr, et al.
Blood|July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemiaBing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndromeHany Ariffin, Pierre Hainaut, Anna Puzio-Kuter, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Clinical Investigation|August 30, 2008
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse modelCarolyn Waugh Kinkade, Mireia Castillo-Martin, Anna Puzio-Kuter, et al.
Otolaryngologia Polska = the Polish Otolaryngology|July 7, 2022
Innovative System for Evaluation and Rehabilitation of Human ImbalanceAnna Gawrońska, Ewa Zamysłowska-Szmytke, Magdalena Janc, et al.
ACS Medicinal Chemistry Letters|January 15, 2025
Discovery of Rezatapopt (PC14586), a First-in-Class, Small-Molecule Reactivator of p53 Y220C Mutant in DevelopmentBinh T Vu, Romyr Dominique, Bruce J Fahr, et al.
Blood|July 3, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemiaBing Z Carter, Po Yee Mak, Edward Ayoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2014
Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndromeHany Ariffin, Pierre Hainaut, Anna Puzio-Kuter, et al.
Pageof 2